ARESiss -Isolate Sequencing Services for Infection Prevention and Control
Outbreak Surveillance and Infection Prevention require accurate typing and characterization of bacterial isolates. Sequence your isolates with the pathogenomics- and AMR-experts at Ares Genetics and rely on the validated, AI powered ARESiss platform for accurate, comprehensive, and epidemiologically relevant data from microbial isolates.
Sequencing
Amplicon sequencing using short- or long-read technology
Data Analysis and Interpretation
Accurate detection2 of bacteria and fungi via amplicon sequence variant (ASV) detection in the 16S ribosomal rRNA gene, or the eukaryotic ITS region
Reporting of detected microbes and their relative abundance via AREScloud and in standard bioinformatics file formats
Comprehensive Reporting
Microbiome analysis and multi cohort comparison, including alpha diversity and beta diversity analysis
Your Benefits
Accurate surveillance
Reduce antibiotic use
Monitor trends and identify the emergence of new threats
Trace chains of transmission
Improve antimicrobial therapy through predictive AST
Your Benefits
- Accurate surveillance
- Reduce antibiotic use
- Monitor trends and identify the emergence of new threats
- Trace chains of transmission
- Improve antimicrobial therapy through predictive AST
We Offer
- Express turnaround time of 5 days available upon request
- Quality results based on validated ARESiss platform1
- Access to reports via the AREScloud portal
Sequencing
Whole genome sequencing using short- or long-read technology
Data Analysis and Interpretation
Pathogen Characterization
ID & typing (cgMLST, MLST)
AMR marker profiling & annotation
Predictive AST
Virulence marker & plasmid profiling
Advanced Interpretation
Outbreak analysis (optional)
Custom analytics (optional)
Comprehensive Reporting
AREScloud
Web portal for reports and interpretation
Ares Genetics Expertise
An industry leading database and AI powered bioinformatics platform convert isolate genome data into epidemiologically actionable information.
Ares analytics enable accurate pathogen identification1,2 and AMR detection3 in line with FDA requirements for diagnostic antimicrobial susceptibility test (AST) systems.4
Predictive AST is the prediction of antimicrobial susceptibility profiles from genomic data. Resistance markers tell only one side of the story. Whether a pathogen is susceptible to antibiotic therapy can depend on a combination of different genes and genomic mutations. Unlike other solutions that purely rely on AMR gene detection, Ares Genetics aims to set the standard for AI-powered predictive antibiotic susceptibility testing (predictive AST).2,3,5,6,7 Predictive models for a wide range of pathogen-drug combinations are trained using an industry-leading collection of continuously curated clinical pathogen genomes and associated antibiotic susceptibility profiles.